nodes	percent_of_prediction	percent_of_DWPC	metapath
Liotrix—ALB—Crohn's disease	0.333	1	CbGaD
Liotrix—SLC22A8—Mercaptopurine—Crohn's disease	0.144	0.311	CbGbCtD
Liotrix—SLCO1B1—Sulfasalazine—Crohn's disease	0.127	0.274	CbGbCtD
Liotrix—SLCO1A2—Prednisone—Crohn's disease	0.107	0.232	CbGbCtD
Liotrix—ALB—Prednisone—Crohn's disease	0.0555	0.12	CbGbCtD
Liotrix—ABCB1—Prednisone—Crohn's disease	0.029	0.0628	CbGbCtD
Liotrix—SLC10A1—bile—Crohn's disease	0.0143	0.38	CbGeAlD
Liotrix—Infertility—Mesalazine—Crohn's disease	0.00447	0.0434	CcSEcCtD
Liotrix—Intestinal perforation—Azathioprine—Crohn's disease	0.00324	0.0314	CcSEcCtD
Liotrix—Alkalosis—Prednisone—Crohn's disease	0.00308	0.0298	CcSEcCtD
Liotrix—Water retention—Prednisone—Crohn's disease	0.00272	0.0264	CcSEcCtD
Liotrix—Distention—Prednisone—Crohn's disease	0.00262	0.0254	CcSEcCtD
Liotrix—Abdominal bloating—Mesalazine—Crohn's disease	0.00245	0.0238	CcSEcCtD
Liotrix—Ulcer—Mercaptopurine—Crohn's disease	0.00227	0.022	CcSEcCtD
Liotrix—ALB—gall bladder—Crohn's disease	0.00213	0.0566	CbGeAlD
Liotrix—SLCO4C1—mammalian vulva—Crohn's disease	0.0021	0.0558	CbGeAlD
Liotrix—Benign intracranial hypertension—Prednisone—Crohn's disease	0.0021	0.0204	CcSEcCtD
Liotrix—Sepsis—Mercaptopurine—Crohn's disease	0.00187	0.0181	CcSEcCtD
Liotrix—Abdominal cramps—Mesalazine—Crohn's disease	0.00173	0.0168	CcSEcCtD
Liotrix—Intestinal obstruction—Mesalazine—Crohn's disease	0.00171	0.0166	CcSEcCtD
Liotrix—Gastric irritation—Prednisone—Crohn's disease	0.00159	0.0154	CcSEcCtD
Liotrix—SLC10A1—digestive system—Crohn's disease	0.00156	0.0415	CbGeAlD
Liotrix—Hyperthyroidism—Prednisone—Crohn's disease	0.00156	0.0151	CcSEcCtD
Liotrix—Feeling hot—Mesalazine—Crohn's disease	0.00149	0.0144	CcSEcCtD
Liotrix—SLC16A10—epithelium—Crohn's disease	0.00136	0.036	CbGeAlD
Liotrix—SLCO4A1—mammalian vulva—Crohn's disease	0.00134	0.0357	CbGeAlD
Liotrix—Tenderness—Mesalazine—Crohn's disease	0.00134	0.013	CcSEcCtD
Liotrix—TTR—lymphoid tissue—Crohn's disease	0.00133	0.0353	CbGeAlD
Liotrix—TTR—digestive system—Crohn's disease	0.00131	0.0349	CbGeAlD
Liotrix—Hypocalcaemia—Mesalazine—Crohn's disease	0.00127	0.0124	CcSEcCtD
Liotrix—SLCO4A1—digestive system—Crohn's disease	0.00118	0.0313	CbGeAlD
Liotrix—SLC16A10—mammalian vulva—Crohn's disease	0.00118	0.0313	CbGeAlD
Liotrix—Hypernatraemia—Prednisone—Crohn's disease	0.00117	0.0114	CcSEcCtD
Liotrix—Epigastric discomfort—Prednisone—Crohn's disease	0.00117	0.0114	CcSEcCtD
Liotrix—Menstruation irregular—Prednisone—Crohn's disease	0.00112	0.0108	CcSEcCtD
Liotrix—Blood urea increased—Mesalazine—Crohn's disease	0.0011	0.0107	CcSEcCtD
Liotrix—Coma—Mesalazine—Crohn's disease	0.00107	0.0103	CcSEcCtD
Liotrix—SLC16A10—lymphoid tissue—Crohn's disease	0.00105	0.0278	CbGeAlD
Liotrix—SLCO1B1—digestive system—Crohn's disease	0.00104	0.0275	CbGeAlD
Liotrix—THRB—lymph node—Crohn's disease	0.00101	0.0268	CbGeAlD
Liotrix—THRA—lymph node—Crohn's disease	0.00101	0.0268	CbGeAlD
Liotrix—Alopecia—Mercaptopurine—Crohn's disease	0.000954	0.00925	CcSEcCtD
Liotrix—Disorientation—Mesalazine—Crohn's disease	0.000947	0.00918	CcSEcCtD
Liotrix—Renal failure acute—Mesalazine—Crohn's disease	0.000917	0.0089	CcSEcCtD
Liotrix—SLC16A2—lymph node—Crohn's disease	0.000916	0.0243	CbGeAlD
Liotrix—Increased appetite—Mesalazine—Crohn's disease	0.000902	0.00874	CcSEcCtD
Liotrix—Renal impairment—Mesalazine—Crohn's disease	0.00089	0.00863	CcSEcCtD
Liotrix—SLCO1A2—digestive system—Crohn's disease	0.000844	0.0224	CbGeAlD
Liotrix—SLCO1C1—lymph node—Crohn's disease	0.00084	0.0223	CbGeAlD
Liotrix—Affect lability—Mesalazine—Crohn's disease	0.000834	0.00809	CcSEcCtD
Liotrix—Mood swings—Mesalazine—Crohn's disease	0.000802	0.00778	CcSEcCtD
Liotrix—Arthralgia—Mercaptopurine—Crohn's disease	0.0008	0.00776	CcSEcCtD
Liotrix—Blood creatinine increased—Mesalazine—Crohn's disease	0.000794	0.0077	CcSEcCtD
Liotrix—Necrosis—Prednisone—Crohn's disease	0.000787	0.00763	CcSEcCtD
Liotrix—Abscess—Prednisone—Crohn's disease	0.00078	0.00757	CcSEcCtD
Liotrix—Oedema—Mercaptopurine—Crohn's disease	0.000767	0.00744	CcSEcCtD
Liotrix—Abdominal distension—Mesalazine—Crohn's disease	0.000737	0.00715	CcSEcCtD
Liotrix—Dysphagia—Mesalazine—Crohn's disease	0.000732	0.0071	CcSEcCtD
Liotrix—Anorexia—Mercaptopurine—Crohn's disease	0.000731	0.00709	CcSEcCtD
Liotrix—Bronchospasm—Mesalazine—Crohn's disease	0.00072	0.00698	CcSEcCtD
Liotrix—Angina pectoris—Mesalazine—Crohn's disease	0.000713	0.00692	CcSEcCtD
Liotrix—Levothyroxine—ALB—Crohn's disease	0.00071	0.584	CrCbGaD
Liotrix—Bronchitis—Mesalazine—Crohn's disease	0.000704	0.00683	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000699	0.00678	CcSEcCtD
Liotrix—SLCO4A1—lymph node—Crohn's disease	0.000673	0.0179	CbGeAlD
Liotrix—Decreased appetite—Mercaptopurine—Crohn's disease	0.000667	0.00647	CcSEcCtD
Liotrix—Weight decreased—Mesalazine—Crohn's disease	0.000662	0.00642	CcSEcCtD
Liotrix—Ulcer—Prednisone—Crohn's disease	0.000653	0.00633	CcSEcCtD
Liotrix—Renal failure—Mesalazine—Crohn's disease	0.000642	0.00622	CcSEcCtD
Liotrix—Sweating—Mesalazine—Crohn's disease	0.000626	0.00607	CcSEcCtD
Liotrix—Body temperature increased—Mercaptopurine—Crohn's disease	0.000606	0.00588	CcSEcCtD
Liotrix—SLC16A10—lymph node—Crohn's disease	0.00059	0.0157	CbGeAlD
Liotrix—Fluid retention—Prednisone—Crohn's disease	0.000586	0.00568	CcSEcCtD
Liotrix—Arrhythmia—Azathioprine—Crohn's disease	0.000575	0.00557	CcSEcCtD
Liotrix—Alopecia—Azathioprine—Crohn's disease	0.000568	0.00551	CcSEcCtD
Liotrix—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000565	0.00548	CcSEcCtD
Liotrix—Hyperkinesia—Prednisone—Crohn's disease	0.000538	0.00522	CcSEcCtD
Liotrix—Sepsis—Prednisone—Crohn's disease	0.000536	0.0052	CcSEcCtD
Liotrix—Diarrhoea—Mercaptopurine—Crohn's disease	0.000525	0.00509	CcSEcCtD
Liotrix—Alopecia—Mesalazine—Crohn's disease	0.000518	0.00502	CcSEcCtD
Liotrix—Liothyronine—ALB—Crohn's disease	0.000506	0.416	CrCbGaD
Liotrix—Flatulence—Mesalazine—Crohn's disease	0.000503	0.00487	CcSEcCtD
Liotrix—Tension—Mesalazine—Crohn's disease	0.000501	0.00485	CcSEcCtD
Liotrix—Dysgeusia—Mesalazine—Crohn's disease	0.0005	0.00484	CcSEcCtD
Liotrix—Nervousness—Mesalazine—Crohn's disease	0.000495	0.0048	CcSEcCtD
Liotrix—Cardiac failure congestive—Prednisone—Crohn's disease	0.000494	0.00479	CcSEcCtD
Liotrix—Vomiting—Mercaptopurine—Crohn's disease	0.000488	0.00473	CcSEcCtD
Liotrix—Rash—Mercaptopurine—Crohn's disease	0.000484	0.00469	CcSEcCtD
Liotrix—Dermatitis—Mercaptopurine—Crohn's disease	0.000483	0.00469	CcSEcCtD
Liotrix—Vision blurred—Mesalazine—Crohn's disease	0.000481	0.00466	CcSEcCtD
Liotrix—ALB—lymph node—Crohn's disease	0.000479	0.0127	CbGeAlD
Liotrix—Tremor—Mesalazine—Crohn's disease	0.000478	0.00463	CcSEcCtD
Liotrix—Increased appetite—Prednisone—Crohn's disease	0.000477	0.00463	CcSEcCtD
Liotrix—Arthralgia—Azathioprine—Crohn's disease	0.000477	0.00462	CcSEcCtD
Liotrix—Angioedema—Mesalazine—Crohn's disease	0.000466	0.00452	CcSEcCtD
Liotrix—Cardiac failure—Prednisone—Crohn's disease	0.000459	0.00445	CcSEcCtD
Liotrix—Syncope—Mesalazine—Crohn's disease	0.000457	0.00444	CcSEcCtD
Liotrix—Nausea—Mercaptopurine—Crohn's disease	0.000456	0.00442	CcSEcCtD
Liotrix—Infection—Azathioprine—Crohn's disease	0.000454	0.0044	CcSEcCtD
Liotrix—Palpitations—Mesalazine—Crohn's disease	0.000451	0.00437	CcSEcCtD
Liotrix—Loss of consciousness—Mesalazine—Crohn's disease	0.000448	0.00435	CcSEcCtD
Liotrix—Affect lability—Prednisone—Crohn's disease	0.000441	0.00428	CcSEcCtD
Liotrix—Hypertension—Mesalazine—Crohn's disease	0.00044	0.00427	CcSEcCtD
Liotrix—Arthralgia—Mesalazine—Crohn's disease	0.000434	0.00421	CcSEcCtD
Liotrix—Chest pain—Mesalazine—Crohn's disease	0.000434	0.00421	CcSEcCtD
Liotrix—Anxiety—Mesalazine—Crohn's disease	0.000433	0.0042	CcSEcCtD
Liotrix—Irritability—Prednisone—Crohn's disease	0.000428	0.00415	CcSEcCtD
Liotrix—Hypotension—Azathioprine—Crohn's disease	0.000427	0.00414	CcSEcCtD
Liotrix—Cardiac arrest—Prednisone—Crohn's disease	0.000426	0.00413	CcSEcCtD
Liotrix—Mood swings—Prednisone—Crohn's disease	0.000425	0.00412	CcSEcCtD
Liotrix—Confusional state—Mesalazine—Crohn's disease	0.00042	0.00407	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000416	0.00404	CcSEcCtD
Liotrix—Anaphylactic shock—Mesalazine—Crohn's disease	0.000416	0.00404	CcSEcCtD
Liotrix—Oedema—Mesalazine—Crohn's disease	0.000416	0.00404	CcSEcCtD
Liotrix—Infection—Mesalazine—Crohn's disease	0.000414	0.00401	CcSEcCtD
Liotrix—Shock—Mesalazine—Crohn's disease	0.00041	0.00397	CcSEcCtD
Liotrix—Hypokalaemia—Prednisone—Crohn's disease	0.000408	0.00396	CcSEcCtD
Liotrix—Tachycardia—Mesalazine—Crohn's disease	0.000406	0.00394	CcSEcCtD
Liotrix—Hyperhidrosis—Mesalazine—Crohn's disease	0.000402	0.0039	CcSEcCtD
Liotrix—Anorexia—Mesalazine—Crohn's disease	0.000397	0.00385	CcSEcCtD
Liotrix—Muscular weakness—Prednisone—Crohn's disease	0.000395	0.00383	CcSEcCtD
Liotrix—Abdominal distension—Prednisone—Crohn's disease	0.00039	0.00378	CcSEcCtD
Liotrix—Hypotension—Mesalazine—Crohn's disease	0.000389	0.00377	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000379	0.00368	CcSEcCtD
Liotrix—Sweating increased—Prednisone—Crohn's disease	0.000377	0.00366	CcSEcCtD
Liotrix—Feeling abnormal—Azathioprine—Crohn's disease	0.000377	0.00365	CcSEcCtD
Liotrix—Insomnia—Mesalazine—Crohn's disease	0.000377	0.00365	CcSEcCtD
Liotrix—Paraesthesia—Mesalazine—Crohn's disease	0.000374	0.00363	CcSEcCtD
Liotrix—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000374	0.00362	CcSEcCtD
Liotrix—ABCB1—epithelium—Crohn's disease	0.000372	0.00986	CbGeAlD
Liotrix—Dyspnoea—Mesalazine—Crohn's disease	0.000371	0.0036	CcSEcCtD
Liotrix—Decreased appetite—Mesalazine—Crohn's disease	0.000362	0.00351	CcSEcCtD
Liotrix—Abdominal pain—Azathioprine—Crohn's disease	0.000361	0.0035	CcSEcCtD
Liotrix—Body temperature increased—Azathioprine—Crohn's disease	0.000361	0.0035	CcSEcCtD
Liotrix—Fatigue—Mesalazine—Crohn's disease	0.000359	0.00348	CcSEcCtD
Liotrix—Constipation—Mesalazine—Crohn's disease	0.000356	0.00345	CcSEcCtD
Liotrix—Weight decreased—Prednisone—Crohn's disease	0.00035	0.0034	CcSEcCtD
Liotrix—Feeling abnormal—Mesalazine—Crohn's disease	0.000343	0.00333	CcSEcCtD
Liotrix—Acute coronary syndrome—Prednisone—Crohn's disease	0.00034	0.0033	CcSEcCtD
Liotrix—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00034	0.0033	CcSEcCtD
Liotrix—Myocardial infarction—Prednisone—Crohn's disease	0.000339	0.00328	CcSEcCtD
Liotrix—Hypersensitivity—Azathioprine—Crohn's disease	0.000337	0.00327	CcSEcCtD
Liotrix—Urticaria—Mesalazine—Crohn's disease	0.000331	0.00321	CcSEcCtD
Liotrix—Abdominal pain—Mesalazine—Crohn's disease	0.000329	0.00319	CcSEcCtD
Liotrix—Body temperature increased—Mesalazine—Crohn's disease	0.000329	0.00319	CcSEcCtD
Liotrix—ABCB1—mammalian vulva—Crohn's disease	0.000322	0.00855	CbGeAlD
Liotrix—Diarrhoea—Azathioprine—Crohn's disease	0.000313	0.00303	CcSEcCtD
Liotrix—Hypersensitivity—Mesalazine—Crohn's disease	0.000307	0.00297	CcSEcCtD
Liotrix—Dizziness—Azathioprine—Crohn's disease	0.000302	0.00293	CcSEcCtD
Liotrix—Asthenia—Mesalazine—Crohn's disease	0.000299	0.0029	CcSEcCtD
Liotrix—Pruritus—Mesalazine—Crohn's disease	0.000295	0.00286	CcSEcCtD
Liotrix—Vomiting—Azathioprine—Crohn's disease	0.000291	0.00282	CcSEcCtD
Liotrix—Rash—Azathioprine—Crohn's disease	0.000288	0.00279	CcSEcCtD
Liotrix—Dermatitis—Azathioprine—Crohn's disease	0.000288	0.00279	CcSEcCtD
Liotrix—Flushing—Prednisone—Crohn's disease	0.000288	0.00279	CcSEcCtD
Liotrix—Headache—Azathioprine—Crohn's disease	0.000286	0.00278	CcSEcCtD
Liotrix—ABCB1—lymphoid tissue—Crohn's disease	0.000286	0.00759	CbGeAlD
Liotrix—Diarrhoea—Mesalazine—Crohn's disease	0.000285	0.00276	CcSEcCtD
Liotrix—ABCB1—digestive system—Crohn's disease	0.000283	0.0075	CbGeAlD
Liotrix—Arrhythmia—Prednisone—Crohn's disease	0.000277	0.00269	CcSEcCtD
Liotrix—Dizziness—Mesalazine—Crohn's disease	0.000275	0.00267	CcSEcCtD
Liotrix—Alopecia—Prednisone—Crohn's disease	0.000274	0.00266	CcSEcCtD
Liotrix—Nausea—Azathioprine—Crohn's disease	0.000271	0.00263	CcSEcCtD
Liotrix—Vomiting—Mesalazine—Crohn's disease	0.000265	0.00257	CcSEcCtD
Liotrix—Rash—Mesalazine—Crohn's disease	0.000262	0.00255	CcSEcCtD
Liotrix—Dermatitis—Mesalazine—Crohn's disease	0.000262	0.00254	CcSEcCtD
Liotrix—Headache—Mesalazine—Crohn's disease	0.000261	0.00253	CcSEcCtD
Liotrix—Vision blurred—Prednisone—Crohn's disease	0.000254	0.00247	CcSEcCtD
Liotrix—Agitation—Prednisone—Crohn's disease	0.000248	0.00241	CcSEcCtD
Liotrix—Nausea—Mesalazine—Crohn's disease	0.000247	0.0024	CcSEcCtD
Liotrix—Angioedema—Prednisone—Crohn's disease	0.000247	0.00239	CcSEcCtD
Liotrix—Syncope—Prednisone—Crohn's disease	0.000242	0.00235	CcSEcCtD
Liotrix—Loss of consciousness—Prednisone—Crohn's disease	0.000237	0.0023	CcSEcCtD
Liotrix—Convulsion—Prednisone—Crohn's disease	0.000234	0.00227	CcSEcCtD
Liotrix—Hypertension—Prednisone—Crohn's disease	0.000233	0.00226	CcSEcCtD
Liotrix—Arthralgia—Prednisone—Crohn's disease	0.00023	0.00223	CcSEcCtD
Liotrix—Anxiety—Prednisone—Crohn's disease	0.000229	0.00222	CcSEcCtD
Liotrix—Anaphylactic shock—Prednisone—Crohn's disease	0.00022	0.00214	CcSEcCtD
Liotrix—Oedema—Prednisone—Crohn's disease	0.00022	0.00214	CcSEcCtD
Liotrix—Infection—Prednisone—Crohn's disease	0.000219	0.00212	CcSEcCtD
Liotrix—SLCO1B3—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000218	0.00349	CbGpPWpGaD
Liotrix—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—Crohn's disease	0.000218	0.00348	CbGpPWpGaD
Liotrix—Shock—Prednisone—Crohn's disease	0.000217	0.0021	CcSEcCtD
Liotrix—ALB—Response to elevated platelet cytosolic Ca2+—F5—Crohn's disease	0.000215	0.00344	CbGpPWpGaD
Liotrix—Tachycardia—Prednisone—Crohn's disease	0.000215	0.00208	CcSEcCtD
Liotrix—Hyperhidrosis—Prednisone—Crohn's disease	0.000213	0.00206	CcSEcCtD
Liotrix—Anorexia—Prednisone—Crohn's disease	0.00021	0.00204	CcSEcCtD
Liotrix—THRA—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.000209	0.00335	CbGpPWpGaD
Liotrix—THRB—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.000209	0.00335	CbGpPWpGaD
Liotrix—SLCO1B1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000208	0.00333	CbGpPWpGaD
Liotrix—SLCO1B1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000208	0.00333	CbGpPWpGaD
Liotrix—SLCO4C1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000207	0.00331	CbGpPWpGaD
Liotrix—SLCO4A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000207	0.00331	CbGpPWpGaD
Liotrix—ALB—Selenium Micronutrient Network—GPX4—Crohn's disease	0.000207	0.0033	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000206	0.0033	CbGpPWpGaD
Liotrix—SLC16A10—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000202	0.00323	CbGpPWpGaD
Liotrix—SLC16A10—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000202	0.00323	CbGpPWpGaD
Liotrix—THRB—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.000201	0.00322	CbGpPWpGaD
Liotrix—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000201	0.00195	CcSEcCtD
Liotrix—THRB—Gene Expression—ZFP36L1—Crohn's disease	0.0002	0.0032	CbGpPWpGaD
Liotrix—THRA—Gene Expression—ZFP36L1—Crohn's disease	0.0002	0.0032	CbGpPWpGaD
Liotrix—Insomnia—Prednisone—Crohn's disease	0.000199	0.00193	CcSEcCtD
Liotrix—ALB—Folate Metabolism—MPO—Crohn's disease	0.000198	0.00317	CbGpPWpGaD
Liotrix—Paraesthesia—Prednisone—Crohn's disease	0.000198	0.00192	CcSEcCtD
Liotrix—SLCO1C1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000196	0.00314	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000195	0.00312	CbGpPWpGaD
Liotrix—SLC22A8—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000193	0.00309	CbGpPWpGaD
Liotrix—SLCO1B3—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000193	0.00309	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000193	0.00309	CbGpPWpGaD
Liotrix—THRB—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.000193	0.00309	CbGpPWpGaD
Liotrix—Decreased appetite—Prednisone—Crohn's disease	0.000191	0.00186	CcSEcCtD
Liotrix—Fatigue—Prednisone—Crohn's disease	0.00019	0.00184	CcSEcCtD
Liotrix—Constipation—Prednisone—Crohn's disease	0.000188	0.00183	CcSEcCtD
Liotrix—Feeling abnormal—Prednisone—Crohn's disease	0.000182	0.00176	CcSEcCtD
Liotrix—Gastrointestinal pain—Prednisone—Crohn's disease	0.00018	0.00175	CcSEcCtD
Liotrix—Urticaria—Prednisone—Crohn's disease	0.000175	0.0017	CcSEcCtD
Liotrix—Abdominal pain—Prednisone—Crohn's disease	0.000174	0.00169	CcSEcCtD
Liotrix—Body temperature increased—Prednisone—Crohn's disease	0.000174	0.00169	CcSEcCtD
Liotrix—SLCO1C1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000173	0.00277	CbGpPWpGaD
Liotrix—SLCO1A2—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000172	0.00275	CbGpPWpGaD
Liotrix—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000171	0.00273	CbGpPWpGaD
Liotrix—THRA—Gene Expression—DNMT3A—Crohn's disease	0.00017	0.00272	CbGpPWpGaD
Liotrix—THRB—Gene Expression—DNMT3A—Crohn's disease	0.00017	0.00272	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000166	0.00265	CbGpPWpGaD
Liotrix—Hypersensitivity—Prednisone—Crohn's disease	0.000162	0.00157	CcSEcCtD
Liotrix—ABCB1—lymph node—Crohn's disease	0.000162	0.00428	CbGeAlD
Liotrix—Asthenia—Prednisone—Crohn's disease	0.000158	0.00153	CcSEcCtD
Liotrix—SLCO1B3—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000158	0.00252	CbGpPWpGaD
Liotrix—SLCO1B3—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000158	0.00252	CbGpPWpGaD
Liotrix—ALB—Selenium Micronutrient Network—MPO—Crohn's disease	0.000158	0.00252	CbGpPWpGaD
Liotrix—Pruritus—Prednisone—Crohn's disease	0.000156	0.00151	CcSEcCtD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000153	0.00245	CbGpPWpGaD
Liotrix—SLCO1A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000152	0.00243	CbGpPWpGaD
Liotrix—Diarrhoea—Prednisone—Crohn's disease	0.000151	0.00146	CcSEcCtD
Liotrix—THRA—Generic Transcription Pathway—SMAD3—Crohn's disease	0.00015	0.00239	CbGpPWpGaD
Liotrix—THRB—Generic Transcription Pathway—SMAD3—Crohn's disease	0.00015	0.00239	CbGpPWpGaD
Liotrix—SLCO1B1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000147	0.00235	CbGpPWpGaD
Liotrix—SLCO4C1—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000146	0.00234	CbGpPWpGaD
Liotrix—SLCO4A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000146	0.00234	CbGpPWpGaD
Liotrix—TTR—Disease—RSPO3—Crohn's disease	0.000146	0.00234	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000146	0.00233	CbGpPWpGaD
Liotrix—Dizziness—Prednisone—Crohn's disease	0.000146	0.00141	CcSEcCtD
Liotrix—SLC16A10—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000142	0.00227	CbGpPWpGaD
Liotrix—THRB—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.00014	0.00224	CbGpPWpGaD
Liotrix—Vomiting—Prednisone—Crohn's disease	0.00014	0.00136	CcSEcCtD
Liotrix—SLC22A8—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000139	0.00223	CbGpPWpGaD
Liotrix—SLC22A8—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000139	0.00223	CbGpPWpGaD
Liotrix—Rash—Prednisone—Crohn's disease	0.000139	0.00135	CcSEcCtD
Liotrix—Dermatitis—Prednisone—Crohn's disease	0.000139	0.00135	CcSEcCtD
Liotrix—TTR—Disease—SEL1L—Crohn's disease	0.000139	0.00222	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PLA2G4F—Crohn's disease	0.000139	0.00222	CbGpPWpGaD
Liotrix—ABCB1—Allograft Rejection—IL17A—Crohn's disease	0.000138	0.00221	CbGpPWpGaD
Liotrix—Headache—Prednisone—Crohn's disease	0.000138	0.00134	CcSEcCtD
Liotrix—TTR—Signaling Pathways—ACKR2—Crohn's disease	0.000135	0.00216	CbGpPWpGaD
Liotrix—TTR—Extracellular matrix organization—ICAM1—Crohn's disease	0.000133	0.00213	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000131	0.00209	CbGpPWpGaD
Liotrix—Nausea—Prednisone—Crohn's disease	0.000131	0.00127	CcSEcCtD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.00013	0.00208	CbGpPWpGaD
Liotrix—SLCO1B1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.00013	0.00208	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000129	0.00207	CbGpPWpGaD
Liotrix—ABCB1—Allograft Rejection—IL12B—Crohn's disease	0.000129	0.00206	CbGpPWpGaD
Liotrix—ALB—Vitamin B12 Metabolism—CRP—Crohn's disease	0.000128	0.00205	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MLN—Crohn's disease	0.000128	0.00205	CbGpPWpGaD
Liotrix—SLC16A10—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000126	0.00201	CbGpPWpGaD
Liotrix—TTR—Disease—LTF—Crohn's disease	0.000124	0.00199	CbGpPWpGaD
Liotrix—SLCO1A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000124	0.00198	CbGpPWpGaD
Liotrix—SLCO1A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000124	0.00198	CbGpPWpGaD
Liotrix—SLCO1C1—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000123	0.00196	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000121	0.00193	CbGpPWpGaD
Liotrix—CYP2C8—Metapathway biotransformation—GPX4—Crohn's disease	0.00012	0.00192	CbGpPWpGaD
Liotrix—ALB—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000119	0.0019	CbGpPWpGaD
Liotrix—ALB—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000119	0.0019	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—MTMR3—Crohn's disease	0.000118	0.00189	CbGpPWpGaD
Liotrix—ALB—Vitamin B12 Metabolism—ICAM1—Crohn's disease	0.000118	0.00188	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—TAGAP—Crohn's disease	0.000117	0.00187	CbGpPWpGaD
Liotrix—THRB—Gene Expression—HSPA1B—Crohn's disease	0.000115	0.00184	CbGpPWpGaD
Liotrix—THRA—Gene Expression—HSPA1B—Crohn's disease	0.000115	0.00184	CbGpPWpGaD
Liotrix—THRB—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.000113	0.00181	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000111	0.00178	CbGpPWpGaD
Liotrix—SLCO1B3—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000111	0.00178	CbGpPWpGaD
Liotrix—SLCO1B1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000106	0.00169	CbGpPWpGaD
Liotrix—SLCO1B1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000106	0.00169	CbGpPWpGaD
Liotrix—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	0.000105	0.00167	CbGpPWpGaD
Liotrix—ALB—Folate Metabolism—CRP—Crohn's disease	0.000104	0.00167	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—RSPO3—Crohn's disease	0.000102	0.00164	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000101	0.00162	CbGpPWpGaD
Liotrix—THRA—Gene Expression—UBE2D1—Crohn's disease	0.000101	0.00161	CbGpPWpGaD
Liotrix—THRB—Gene Expression—UBE2D1—Crohn's disease	0.000101	0.00161	CbGpPWpGaD
Liotrix—TTR—Disease—GCKR—Crohn's disease	0.0001	0.0016	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—F5—Crohn's disease	0.0001	0.0016	CbGpPWpGaD
Liotrix—SLC22A8—Transmembrane transport of small molecules—GCKR—Crohn's disease	9.82e-05	0.00157	CbGpPWpGaD
Liotrix—SLCO1B3—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	9.81e-05	0.00157	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—SEL1L—Crohn's disease	9.71e-05	0.00155	CbGpPWpGaD
Liotrix—ALB—Folate Metabolism—ICAM1—Crohn's disease	9.58e-05	0.00153	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	9.5e-05	0.00152	CbGpPWpGaD
Liotrix—ABCB1—Allograft Rejection—IL10—Crohn's disease	9.41e-05	0.00151	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—FADS1—Crohn's disease	9.18e-05	0.00147	CbGpPWpGaD
Liotrix—ALB—Vitamin B12 Metabolism—IFNG—Crohn's disease	8.96e-05	0.00143	CbGpPWpGaD
Liotrix—SLC16A10—SLC-mediated transmembrane transport—ALB—Crohn's disease	8.9e-05	0.00142	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CCR9—Crohn's disease	8.88e-05	0.00142	CbGpPWpGaD
Liotrix—TTR—Disease—SLC11A1—Crohn's disease	8.86e-05	0.00142	CbGpPWpGaD
Liotrix—CYP2C8—Arachidonic acid metabolism—PTGS2—Crohn's disease	8.78e-05	0.0014	CbGpPWpGaD
Liotrix—SLCO1A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	8.72e-05	0.0014	CbGpPWpGaD
Liotrix—SLC22A8—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	8.68e-05	0.00139	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PLA2G4F—Crohn's disease	8.68e-05	0.00139	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	8.67e-05	0.00139	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—GPX4—Crohn's disease	8.6e-05	0.00138	CbGpPWpGaD
Liotrix—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	8.39e-05	0.00134	CbGpPWpGaD
Liotrix—ALB—SLC-mediated transmembrane transport—GCKR—Crohn's disease	8.39e-05	0.00134	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—GCKR—Crohn's disease	8.3e-05	0.00133	CbGpPWpGaD
Liotrix—ALB—Selenium Micronutrient Network—CRP—Crohn's disease	8.28e-05	0.00133	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—GPR65—Crohn's disease	8.26e-05	0.00132	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	8.12e-05	0.0013	CbGpPWpGaD
Liotrix—ALB—Vitamin B12 Metabolism—IL1B—Crohn's disease	8e-05	0.00128	CbGpPWpGaD
Liotrix—SLCO1A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	7.71e-05	0.00123	CbGpPWpGaD
Liotrix—ALB—Selenium Micronutrient Network—ICAM1—Crohn's disease	7.61e-05	0.00122	CbGpPWpGaD
Liotrix—TTR—Disease—HSPA1B—Crohn's disease	7.6e-05	0.00122	CbGpPWpGaD
Liotrix—TTR—Disease—RBX1—Crohn's disease	7.6e-05	0.00122	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	7.52e-05	0.0012	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	7.48e-05	0.0012	CbGpPWpGaD
Liotrix—SLCO1B1—Transmembrane transport of small molecules—GCKR—Crohn's disease	7.46e-05	0.00119	CbGpPWpGaD
Liotrix—SLCO4C1—Transmembrane transport of small molecules—ALB—Crohn's disease	7.44e-05	0.00119	CbGpPWpGaD
Liotrix—SLCO4A1—Transmembrane transport of small molecules—ALB—Crohn's disease	7.44e-05	0.00119	CbGpPWpGaD
Liotrix—ALB—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	7.41e-05	0.00119	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—MTMR3—Crohn's disease	7.38e-05	0.00118	CbGpPWpGaD
Liotrix—ALB—Folate Metabolism—IFNG—Crohn's disease	7.29e-05	0.00117	CbGpPWpGaD
Liotrix—THRB—Gene Expression—SMAD3—Crohn's disease	7.2e-05	0.00115	CbGpPWpGaD
Liotrix—THRA—Gene Expression—SMAD3—Crohn's disease	7.2e-05	0.00115	CbGpPWpGaD
Liotrix—SLCO1B3—SLC-mediated transmembrane transport—ALB—Crohn's disease	6.95e-05	0.00111	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PLA2G4F—Crohn's disease	6.82e-05	0.00109	CbGpPWpGaD
Liotrix—TTR—Disease—UBE2D1—Crohn's disease	6.66e-05	0.00107	CbGpPWpGaD
Liotrix—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	6.59e-05	0.00105	CbGpPWpGaD
Liotrix—ALB—Folate Metabolism—IL1B—Crohn's disease	6.51e-05	0.00104	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	6.4e-05	0.00102	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	6.36e-05	0.00102	CbGpPWpGaD
Liotrix—SLCO1C1—Transmembrane transport of small molecules—ALB—Crohn's disease	6.24e-05	0.000998	CbGpPWpGaD
Liotrix—SLC22A8—SLC-mediated transmembrane transport—ALB—Crohn's disease	6.15e-05	0.000984	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	6.05e-05	0.000968	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	6.05e-05	0.000968	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—IL3—Crohn's disease	6e-05	0.00096	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.93e-05	0.000949	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	5.91e-05	0.000945	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CCR6—Crohn's disease	5.88e-05	0.000941	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PLA2G4F—Crohn's disease	5.83e-05	0.000933	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—RASGRP1—Crohn's disease	5.8e-05	0.000929	CbGpPWpGaD
Liotrix—ALB—Vitamin B12 Metabolism—TNF—Crohn's disease	5.8e-05	0.000928	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—MTMR3—Crohn's disease	5.8e-05	0.000928	CbGpPWpGaD
Liotrix—ALB—Selenium Micronutrient Network—IFNG—Crohn's disease	5.79e-05	0.000927	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—FADS1—Crohn's disease	5.75e-05	0.00092	CbGpPWpGaD
Liotrix—ALB—Selenium Micronutrient Network—PTGS2—Crohn's disease	5.55e-05	0.000889	CbGpPWpGaD
Liotrix—ABCB1—Allograft Rejection—IFNG—Crohn's disease	5.53e-05	0.000885	CbGpPWpGaD
Liotrix—SLCO1A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	5.46e-05	0.000874	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—GPX4—Crohn's disease	5.38e-05	0.000861	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—RBX1—Crohn's disease	5.32e-05	0.000851	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	5.3e-05	0.000848	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	5.3e-05	0.000848	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—GCKR—Crohn's disease	5.2e-05	0.000832	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	5.19e-05	0.00083	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PTGER4—Crohn's disease	5.18e-05	0.000829	CbGpPWpGaD
Liotrix—ALB—Selenium Micronutrient Network—IL1B—Crohn's disease	5.17e-05	0.000827	CbGpPWpGaD
Liotrix—ALB—Hemostasis—F5—Crohn's disease	5.16e-05	0.000825	CbGpPWpGaD
Liotrix—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	5.15e-05	0.000823	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	4.98e-05	0.000797	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—MTMR3—Crohn's disease	4.96e-05	0.000793	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	4.96e-05	0.000793	CbGpPWpGaD
Liotrix—ABCB1—Allograft Rejection—IL1B—Crohn's disease	4.94e-05	0.00079	CbGpPWpGaD
Liotrix—TTR—Disease—SMAD3—Crohn's disease	4.77e-05	0.000763	CbGpPWpGaD
Liotrix—ALB—Folate Metabolism—TNF—Crohn's disease	4.72e-05	0.000755	CbGpPWpGaD
Liotrix—ALB—Vitamin B12 Metabolism—IL6—Crohn's disease	4.68e-05	0.000749	CbGpPWpGaD
Liotrix—SLCO1B1—SLC-mediated transmembrane transport—ALB—Crohn's disease	4.67e-05	0.000747	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	4.67e-05	0.000747	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—UBE2D1—Crohn's disease	4.67e-05	0.000746	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	4.64e-05	0.000742	CbGpPWpGaD
Liotrix—SLC16A10—Transmembrane transport of small molecules—ALB—Crohn's disease	4.52e-05	0.000724	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—RIPK2—Crohn's disease	4.52e-05	0.000724	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—FADS1—Crohn's disease	4.52e-05	0.000723	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—IL3—Crohn's disease	4.41e-05	0.000706	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—RASGRP1—Crohn's disease	4.27e-05	0.000683	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—GCKR—Crohn's disease	4.26e-05	0.000682	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—GPX4—Crohn's disease	4.23e-05	0.000677	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	4.2e-05	0.000673	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—GCKR—Crohn's disease	4.09e-05	0.000653	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—SOCS1—Crohn's disease	3.87e-05	0.000618	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—FADS1—Crohn's disease	3.86e-05	0.000618	CbGpPWpGaD
Liotrix—ALB—Folate Metabolism—IL6—Crohn's disease	3.81e-05	0.000609	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	3.77e-05	0.000603	CbGpPWpGaD
Liotrix—ALB—Selenium Micronutrient Network—TNF—Crohn's disease	3.75e-05	0.0006	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	3.73e-05	0.000597	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.72e-05	0.000594	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—GPX4—Crohn's disease	3.62e-05	0.000579	CbGpPWpGaD
Liotrix—ABCB1—Allograft Rejection—TNF—Crohn's disease	3.58e-05	0.000573	CbGpPWpGaD
Liotrix—SLCO1B3—Transmembrane transport of small molecules—ALB—Crohn's disease	3.53e-05	0.000565	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—GCKR—Crohn's disease	3.49e-05	0.000559	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PLA2G4F—Crohn's disease	3.35e-05	0.000536	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—SMAD3—Crohn's disease	3.34e-05	0.000534	CbGpPWpGaD
Liotrix—ALB—Metabolism—PLA2G4F—Crohn's disease	3.33e-05	0.000533	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	3.3e-05	0.000528	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.25e-05	0.00052	CbGpPWpGaD
Liotrix—ALB—Hemostasis—ITGA4—Crohn's disease	3.17e-05	0.000507	CbGpPWpGaD
Liotrix—SLC22A8—Transmembrane transport of small molecules—ALB—Crohn's disease	3.13e-05	0.0005	CbGpPWpGaD
Liotrix—TTR—Disease—TYK2—Crohn's disease	3.11e-05	0.000497	CbGpPWpGaD
Liotrix—ALB—Hemostasis—IL3—Crohn's disease	3.09e-05	0.000495	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—IL2RA—Crohn's disease	3.09e-05	0.000494	CbGpPWpGaD
Liotrix—ALB—Selenium Micronutrient Network—IL6—Crohn's disease	3.03e-05	0.000484	CbGpPWpGaD
Liotrix—ALB—Hemostasis—RASGRP1—Crohn's disease	2.99e-05	0.000479	CbGpPWpGaD
Liotrix—TTR—Disease—JAK2—Crohn's disease	2.97e-05	0.000475	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.92e-05	0.000467	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PLA2G4F—Crohn's disease	2.92e-05	0.000467	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—MTMR3—Crohn's disease	2.85e-05	0.000456	CbGpPWpGaD
Liotrix—ALB—Metabolism—MTMR3—Crohn's disease	2.83e-05	0.000453	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	2.83e-05	0.000452	CbGpPWpGaD
Liotrix—TTR—Disease—CD4—Crohn's disease	2.81e-05	0.00045	CbGpPWpGaD
Liotrix—TTR—Disease—PTGS2—Crohn's disease	2.79e-05	0.000447	CbGpPWpGaD
Liotrix—SLCO1A2—Transmembrane transport of small molecules—ALB—Crohn's disease	2.78e-05	0.000444	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—ALB—Crohn's disease	2.64e-05	0.000423	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	2.62e-05	0.000419	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.55e-05	0.000409	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.5e-05	0.000399	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—MTMR3—Crohn's disease	2.48e-05	0.000397	CbGpPWpGaD
Liotrix—SLCO1B1—Transmembrane transport of small molecules—ALB—Crohn's disease	2.37e-05	0.00038	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PTGS2—Crohn's disease	2.31e-05	0.00037	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—FADS1—Crohn's disease	2.22e-05	0.000355	CbGpPWpGaD
Liotrix—ALB—Metabolism—FADS1—Crohn's disease	2.21e-05	0.000353	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.18e-05	0.000349	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—TYK2—Crohn's disease	2.18e-05	0.000348	CbGpPWpGaD
Liotrix—TTR—Disease—STAT3—Crohn's disease	2.18e-05	0.000348	CbGpPWpGaD
Liotrix—ALB—Hemostasis—IL2RA—Crohn's disease	2.17e-05	0.000347	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GPX4—Crohn's disease	2.08e-05	0.000332	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—JAK2—Crohn's disease	2.08e-05	0.000332	CbGpPWpGaD
Liotrix—ALB—Metabolism—GPX4—Crohn's disease	2.07e-05	0.000331	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GCKR—Crohn's disease	2.01e-05	0.000321	CbGpPWpGaD
Liotrix—ALB—Metabolism—GCKR—Crohn's disease	2e-05	0.000319	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—FADS1—Crohn's disease	1.93e-05	0.000309	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CXCL8—Crohn's disease	1.9e-05	0.000303	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GPX4—Crohn's disease	1.81e-05	0.00029	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	1.77e-05	0.000283	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GCKR—Crohn's disease	1.75e-05	0.00028	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—ALB—Crohn's disease	1.65e-05	0.000265	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—STAT3—Crohn's disease	1.52e-05	0.000244	CbGpPWpGaD
Liotrix—TTR—Disease—IL6—Crohn's disease	1.52e-05	0.000243	CbGpPWpGaD
Liotrix—ALB—Hemostasis—JAK2—Crohn's disease	1.46e-05	0.000233	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PTGS2—Crohn's disease	1.45e-05	0.000232	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.43e-05	0.000229	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—ALB—Crohn's disease	1.3e-05	0.000208	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.26e-05	0.000201	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.25e-05	0.0002	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.19e-05	0.00019	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PTGS2—Crohn's disease	1.14e-05	0.000182	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—ALB—Crohn's disease	1.11e-05	0.000178	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—IL6—Crohn's disease	1.07e-05	0.00017	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PTGS2—Crohn's disease	9.73e-06	0.000156	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ALB—Crohn's disease	6.39e-06	0.000102	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PTGS2—Crohn's disease	5.59e-06	8.94e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ALB—Crohn's disease	5.57e-06	8.9e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PTGS2—Crohn's disease	5.56e-06	8.89e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PTGS2—Crohn's disease	4.87e-06	7.79e-05	CbGpPWpGaD
